Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 4;8(1):15.
doi: 10.1186/s40249-019-0525-9.

HIV prevalence in suspected Ebola cases during the 2014-2016 Ebola epidemic in Sierra Leone

Affiliations

HIV prevalence in suspected Ebola cases during the 2014-2016 Ebola epidemic in Sierra Leone

William J Liu et al. Infect Dis Poverty. .

Abstract

Background: The 2014-2016 Ebola virus epidemic in West Africa was the largest outbreak of Ebola virus disease (EVD) in history. Clarifying the influence of other prevalent diseases such as human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) will help improve treatment and supportive care of patients with EVD.

Case presentation: We examined HIV and hepatitis C virus (HCV) antibody prevalence among suspected EVD cases from the Sierra Leone-China Friendship Biological Safety Laboratory during the epidemic in Sierra Leone. HIV and HCV antibodies were tested in 678 EVD-negative samples by enzyme-linked immunosorbent assay. A high HIV prevalence (17.6%) and low HCV prevalence (0.22%) were observed among the suspected cases. Notably, we found decreased HIV positive rates among the suspected cases over the course of the epidemic. This suggests a potentially beneficial effect of an improved public health system after assistance from the World Health Organization and other international aid organizations.

Conclusions: This EVD epidemic had a considerable impact on the public health system and influenced the prevalence of HIV found among suspected cases in Sierra Leone, but also provided an opportunity to establish a better surveillance network for infectious diseases.

Keywords: Ebola; HCV; HIV; Prevalence; Sierra Leone.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

All manipulations of human samples were approved by the Sierra Leone Ethics and Scientific Review Committee, Directorate of Training and Research, Ministry of Health and Sanitation. The study was conducted in accordance with the tenets of the Declaration of Helsinki and the standards of Good Clinical Practice (as defined by the International Conference on Harmonization).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The prevalence of HIV among EBOV-negative EVD-suspected cases tested at Sierra Leone-China Friendship Biological Safety Laboratory, Sierra Leone, 2015. After its establishment in early 2015, the Sierra Leone-China Friendship Biological Safety Laboratory was responsible for EBOV testing of EVD-suspected patients from most districts of the country. From March to November 2015, 678 individuals were excluded from EBOV infection by real-time PCR method. HIV antibodies in the sera were tested using ELISA (with kits from Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China, and positive cases were confirmed using kits from Zhuhai Livzon Diagnostics Inc., Zhuhai, China). The significant decreases (P < 0.001 in Chi-square tests) in HIV prevalence ratio among the Ebola RNA negative suspected Ebola cases in each month are shown as brown lines and diamond symbols. The monthly reported number of Ebola cases in Sierra Leone by the WHO are shown as blue lines and diamond symbols (http://apps.who.int/gho/data/view.ebola-sitrep.ebola-summary-latest?lang=en) and were significantly correlated with the reported monthly number of Ebola cases (r = 0.745, P = 0.034) using Pearson’s correlation coefficient analyses. EBOV: Ebola virus; EVD: Ebola virus disease; PCR: Polymerase chain reaction; ELISA: Enzyme-linked immunosorbent assay

References

    1. WHO . Ebola outbreak 2014–2015. Geneva: World Health Organization; 2016.
    1. Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M, et al. Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet. 2017. 10.1016/S0140-6736(17)31795-6. - PMC - PubMed
    1. Statistics Sierra Leone SSL Sierra Leone demographic and health survey 2013. Freetown Sierra Leone Statistics Sierra Leone Jul. 2014;42:57–62. - PubMed
    1. Brima N, Burns F, Fakoya I, Kargbo B, Conteh S, Copas A. Factors associated with HIV prevalence and HIV testing in Sierra Leone: findings from the 2008 demographic health survey. PLoS One. 2015;10:e0137055. doi: 10.1371/journal.pone.0137055. - DOI - PMC - PubMed
    1. Li WG, Chen WW, Li L, Ji D, Ji YJ, Li C, et al. The etiology of Ebola virus disease-like illnesses in Ebola virus negative patients from Sierra Leone. Oncotarget. 2016;7:27910–27915. - PMC - PubMed